ReviewAsia-Pacific journal of clinical oncology2022

Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region.

Masatoshi Eto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.